These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22083822)

  • 41. [Proteomics of follicular fluid in mature human follicles and antral follicles: a comparative study with laser desorption/ionization-time of flight-mass spectrometry].
    Li L; Xing FQ; Chen SL; Sun L; Li H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):275-8. PubMed ID: 18250062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial.
    Izmirlian G
    Ann N Y Acad Sci; 2004 May; 1020():154-74. PubMed ID: 15208191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
    Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids.
    Gagnon A; Shi Q; Ye B
    Methods Mol Biol; 2008; 441():41-56. PubMed ID: 18370310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of proteomic signatures of platelet activation using surface-enhanced laser desorption/ionization technology in a clinical setting.
    Yin W; Czuchlewski D; Peerschke EI
    Am J Clin Pathol; 2008 Jun; 129(6):862-9. PubMed ID: 18480001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative proteomic analyses of the yeast Saccharomyces cerevisiae KNU5377 strain against menadione-induced oxidative stress.
    Kim I; Yun H; Jin I
    J Microbiol Biotechnol; 2007 Feb; 17(2):207-17. PubMed ID: 18051751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
    Meilhac O; Delbosc S; Michel JB
    Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
    Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
    Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein expression profiling of brain tumor tissue using SELDI-MS.
    Wibom C
    Methods Mol Biol; 2013; 1023():191-202. PubMed ID: 23765628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using SELDI-TOF mass spectrometry on amniotic fluid and for clinical proteomics and theranostics in disorders of pregnancy.
    Buhimschi IA
    Methods Mol Biol; 2012; 818():171-97. PubMed ID: 22083824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.
    Bouamrani A; Ternier J; Ratel D; Benabid AL; Issartel JP; Brambilla E; Berger F
    Clin Chem; 2006 Nov; 52(11):2103-6. PubMed ID: 16990423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioinformatics strategies for proteomic profiling.
    White CN; Chan DW; Zhang Z
    Clin Biochem; 2004 Jul; 37(7):636-41. PubMed ID: 15234244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data.
    Tang KL; Li TH; Xiong WW; Chen K
    BMC Bioinformatics; 2010 Feb; 11():109. PubMed ID: 20187963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of post-surgical cognitive function and protein fingerprints in the cerebro-spinal fluid utilizing surface-enhanced laser Desorption/Ionization time-of-flight mass-spectrometry (SELDI-TOF MS) after coronary artery bypass grafting: review of proteomic analytic tools and introducing a new syndrome.
    Reis HJ; Wang L; Verano-Braga T; Pimenta AM; Kálmán J; Bogáts G; Babik B; Vieira LB; Teixeira AL; Mukhamedyarov MA; Zefirov AL; Kiyasov AP; Rizvanov AA; Matin K; Palotás M; Guimarães MM; Ferreira CN; Yalvaç ME; Janka Z; Palotás A
    Curr Med Chem; 2011; 18(7):1019-37. PubMed ID: 21254974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacogenomics in neuro-oncology].
    Riese-Jorda HH; Baez JM
    Rev Neurol; 2006 Sep 16-30; 43(6):353-6. PubMed ID: 16981166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of some active Chinese herbal fraction on brain tissue proteomic profile of ischemic mouse].
    Song YY; Wang Z; Qu X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jun; 26(6):526-8. PubMed ID: 16841670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.